Pharmacyclics Inc (PCYC.OQ)

PCYC.OQ on NASDAQ Stock Exchange Global Select Market

119.60USD
23 Sep 2014
Price Change (% chg)

$-0.34 (-0.28%)
Prev Close
$119.94
Open
$120.00
Day's High
$120.25
Day's Low
$119.45
Volume
9,593
Avg. Vol
299,886
52-wk High
$154.89
52-wk Low
$82.56

PCYC.OQ

Chart for PCYC.OQ

About

Pharmacyclics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company's clinical development and product candidates are small-molecule enzyme inhibitors designed to target biochemical pathways involved... (more)

Overall

Beta: 0.64
Market Cap (Mil.): $9,027.88
Shares Outstanding (Mil.): 75.27
Dividend: --
Yield (%): --

Financials

  PCYC.OQ Industry Sector
P/E (TTM): 108.38 145.48 33.86
EPS (TTM): 1.11 -- --
ROI: 14.46 -2.05 17.39
ROE: 15.75 -6.87 18.25
Search Stocks

Pharmacyclics, J&J drug shown to improve leukemia survival

CHICAGO - A new drug for the most common form of leukemia in adults improves survival for patients whose disease has worsened despite standard treatment, according to late-stage study findings released on Saturday.

31 May 2014

UPDATE 1-Pharmacyclics, J&J drug shown to improve leukemia survival

CHICAGO, May 31 - A new drug for the most common form of leukemia in adults improves survival for patients whose disease has worsened despite standard treatment, according to late-stage study findings released on Saturday.

31 May 2014

Pharmacyclics, J&J drug shown to improve leukemia survival

CHICAGO, May 31 - A new drug for the most common form of leukemia in adults improves survival for patients whose disease has worsened despite standard treatment, according to late-stage study findings released on Saturday.

31 May 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks